Differences in the neutrophil/lymphocyte ratio and the platelet/lymphocyte ratio in pregnant women with and without COVID‐19
- 7 August 2021
- journal article
- research article
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 157 (2), 296-302
- https://doi.org/10.1002/ijgo.13840
Abstract
Objective To determine the differences in the neutrophil/lymphocyte ratio (NLR) and the platelet/lymphocyte ratio (PLR) in pregnant women with and without COVID-19. Methods Observational, cross-sectional, retrospective, comparative, open, controlled study done from January to April 2021 at the UMAE Hospital de Gineco Obstetricia “Luis Castelazo Ayala” Instituto Mexicano del Seguro Social. Mexico City, Mexico: Patients were divided into those with a negative test for COVID-19 and those with a positive test, with the latter then being divided according to disease severity into mild, moderate, and severe groups. In all the NLR and PLR were calculated. Symptoms, vital signs, and oxygen saturation were documented. Statistical analysis: Central tendency and dispersion measures, Kruskal-Wallis test, Mann-Whitney U test, and χ2 test were used. Sensitivity, specificity, positive predictive value, negative predictive value, and odds ratio (OR) were calculated. Results Seventy-seven patients were included, 24 without COVID-19 and 53 with COVID-19. There were 33, 10, and 10 patients in the mild, moderate, and severe disease groups, respectively. There was no difference in NLR between the groups and the PLR was significantly higher in the severe disease group. With a 5.1 NLR cutoff point, between normal and those with severe disease, the sensitivity was 70% and specificity 63%, whilst with a 221 PLR cutoff point, the sensitivity was 90% and the specificity 83% (OR 45, 95% CI 4.40-461.7) Conclusion PLR more than NLR was useful to detect pregnant patients with COVID-19 with severe disease.This publication has 28 references indexed in Scilit:
- Higher level of neutrophil-to-lymphocyte is associated with severe COVID-19Epidemiology and Infection, 2020
- Risk factors for disease progression in COVID-19 patientsBMC Infectious Diseases, 2020
- A summary of the diagnostic and prognostic value of hemocytometry markers in COVID-19 patientsCritical Reviews in Clinical Laboratory Sciences, 2020
- Neutrophil-to-Lymphocyte Ratio and Outcomes in Louisiana COVID-19 PatientsShock, 2020
- Lymphopenia in COVID‐19: Therapeutic opportunitiesCell Biology International, 2020
- Neutrophil to lymphocyte ratio as prognostic and predictive factor in patients with coronavirus disease 2019: A retrospective cross‐sectional studyJournal of Medical Virology, 2020
- Platelet‐to‐lymphocyte ratio is associated with prognosis in patients with coronavirus disease‐19Journal of Medical Virology, 2020
- Manipulation of the Innate Immune Response by Varicella Zoster VirusFrontiers in Immunology, 2020
- Use of Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in COVID-19Journal of Clinical Medicine Research, 2020
- Lymphocyte-to-C-Reactive Protein Ratio: A Novel Predictor of Adverse Outcomes in COVID-19Journal of Clinical Medicine Research, 2020